Climb Bio (CLYM) Prepaid Assets (2020 - 2026)
Climb Bio's (CLYM) quarterly Prepaid Assets came in at $3.8 million in Q1 2026, up 517.36% YoY from $622000.0 in Q1 2025, and down 19.48% on a QoQ basis from $4.8 million in Q4 2025.
Climb Bio (CLYM) Prepaid Assets (2020 - 2026) Analysis & Trends
Climb Bio (CLYM) has 7 years of Prepaid Assets data on file, last reported at $3.8 million in Q1 2026.
- Quarterly Prepaid Assets rose 517.36% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 517.36% YoY) and the FY2025 annual result came in at $4.8 million, up 20.64% from the prior year.
- Prepaid Assets declined to $3.8 million in Q1 2026, from $4.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.1 million in Q2 2022 to a low of $622000.0 in Q1 2025.
- A 5-year average of $3.1 million and a median of $2.9 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets sank 88.91% — and 2026, when it jumped 517.36%.
- Tracing CLYM's Prepaid Assets over 5 years: stood at $1.3 million in 2022, then slumped by 36.32% to $847000.0 in 2023, then soared by 366.71% to $4.0 million in 2024, then advanced by 20.64% to $4.8 million in 2025, then decreased by 19.48% to $3.8 million in 2026.
- The last three Prepaid Assets figures came in at $3.8 million (Q1 2026), $4.8 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Climb Bio | 1.24 Bn | 1.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Mar 31, 2026 | 3.84 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Sep 30, 2025 | 4.06 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 622,000.00 |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.86 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 847,000.00 |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 927,000.00 |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 10.13 Mn |
| Mar 31, 2022 | 873,000.00 |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 12.61 Mn |